Onderneming Edwards Lifesciences Corporation BOERSE MUENCHEN
Aandelen
EWL
US28176E1082
Geavanceerde medische apparatuur & technologie
Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
80,61 EUR | -1,15% | -0,92% | +16,67% |
22/05 | EDWARDS LIFESCIENCES CORPORATION : Citigroup verhoogt advies van Neutraal naar Kopen | ZM |
14/05 | EDWARDS LIFESCIENCES CORPORATION : Deutsche Bank Securities past advies aan | ZM |
Vakgebied
- hartkleppen en chirurgische producten (67,9%);
- hemodynamische bewakingssystemen (15,5%);
- overige (16,6%): ballonkatheters, kunstmatige implantaten, enz.
De netto-omzet is als volgt geografisch verdeeld: Verenigde Staten (58,4%), Europa (22,2%), Japan (7,6%) en overige (11,8%).
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta | ||
---|---|---|---|---|---|---|---|
Transcatheter Mitral and Tricuspid Therapies
64,6
%
| 3 518 | 65,4 % | 116 | 2,2 % | 3 880 | 64,6 % | +3.241,77% |
Surgical Heart Valve Therapy
16,6
%
| 893 | 16,6 % | 999 | 16,6 % | +11,89% | ||
Critical Care
15,5
%
| 855 | 15,9 % | 928 | 15,5 % | +8,55% | ||
Transcatheter Mitral and Tricuspid Therapies
3,3
%
| 3 518 | 65,4 % | 116 | 2,2 % | 198 | 3,3 % | +70,20% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
58,4
%
| 3 133 | 58,2 % | 3 509 | 58,4 % | +12,01% |
Europe
22,2
%
| 1 175 | 21,8 % | 1 335 | 22,2 % | +13,59% |
Rest of World
11,8
%
| 601 | 11,2 % | 709 | 11,8 % | +17,92% |
Japan
7,5
%
| 474 | 8,8 % | 452 | 7,5 % | -4,48% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-01-15 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01-01-14 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-19 |
Investor Relations Contact | - | - | |
Tim Patz
SAM | Sales & Marketing | - | 01-07-05 |
Daveen Chopra
PRN | Corporate Officer/Principal | 45 | - |
Linda Park
LAW | General Counsel | 46 | - |
Corporate Officer/Principal | 66 | 01-07-17 | |
Tammy Perry
PRN | Corporate Officer/Principal | - | 01-07-11 |
Donald Bobo
PRN | Corporate Officer/Principal | 62 | 01-01-95 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 05-07-16 |
Chairman | 67 | 13-11-14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-16 |
Paul LaViolette
BRD | Director/Board Member | 66 | 13-07-20 |
Kieran Gallahue
BRD | Director/Board Member | 60 | 10-02-15 |
Ramona Sequeira
BRD | Director/Board Member | 58 | 07-05-20 |
Chief Executive Officer | 56 | 01-01-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 652 000 000 | 597 178 790 ( 91,59 %) | 49 400 000 ( 7,577 %) | 91,59 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Edwards Lifesciences (India) Pvt Ltd.
Edwards Lifesciences (India) Pvt Ltd. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences (India) Pvt Ltd. is an Indian company that designs, develops, manufactures and markets products to treat late-stage cardiovascular disease. The company is based in Mumbai, India. |
Medical Specialties
|
Edwards Lifesciences World Trade Corp.
Edwards Lifesciences World Trade Corp. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences World Trade Corp. is an American company. The company is located in the US. |
Medical Specialties
|
Edwards Lifesciences Technology SARL
| |
Edwards Lifesciences AG
Edwards Lifesciences AG Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences AG is a Swiss company that manufactures and distributes healthcare equipment. The company is based in Nyon, Switzerland. |
Medical Specialties
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,03% | 223 mld. | |
+13,59% | 195 mld. | |
+20,01% | 144 mld. | |
+30,83% | 111 mld. | |
+2,89% | 65,19 mld. | |
+3,64% | 50,28 mld. | |
+8,37% | 44,15 mld. | |
+3,27% | 36,45 mld. | |
+23,97% | 31,33 mld. |